Search results
Results from the WOW.Com Content Network
Tyrosine kinase inhibitor (TKI) with selective activity against RET, VEGFR-2 and EGFR: Medullary thyroid cancer. Diarrhoea, hypertension, QT interval prolongation, depression, electrolyte anomalies, hypothyroidism and GI perforation (uncommon). 2.3 mTOR inhibitors: Everolimus: PO: mTOR inhibitor.
Download as PDF; Printable version; In other projects Wikimedia Commons; Wikidata item; ... Phosphoinositide 3-kinase inhibitors (17 P) Protein kinase inhibitors ...
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
Download as PDF; Printable version; In other projects Wikidata item; Appearance. ... Pages in category "Janus kinase inhibitors" The following 12 pages are in this ...
Download as PDF; Printable version; In other projects Wikimedia Commons; Wikidata item; Appearance. ... Interleukin-1 receptor-associated kinase 4 inhibitors (2 P) K.
A Janus kinase inhibitor, also known as JAK inhibitor or jakinib, [1] is a type of immune modulating medication, which inhibits the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway in lymphocytes.
Download as PDF; Printable version; In other projects ... Pages in category "Phosphoinositide 3-kinase inhibitors" ... This list may not reflect recent changes. ...